VCNX: Dhuwit awis diétung saben siji saham Vaccinex Inc

Vaccinex Inc - logo grafis emiten VCNX

Vaccinex, Inc. (VCNX) is implementing ESG principles by reducing chemical waste during the development of immunotherapies. This approach complements a scaling model based on licensing patents to global partners. This cash per share chart confirms liquidity, where the value of 0.00 expresses the metric level. Operational efficiency is maintained through the full delegation of clinical trials to external CRO centers under strict management oversight.

Vaccinex, Inc. (VCNX) - Dhuwit awis saben saham saka 04.07.2022 nganti 28.12.2024

Rincian metrik komprehensif lan analitis vaccinex.com (VCNX)

- kuotasi saiki lan rata-rata prakiraan nilai:
- informasi kapitalisasi pasar:
- indikator anane dhuwit lan arus kas:
Analisis komprehensif perusahaan:Vaccinex, Inc. (VCNX)
Barang unggulan Vaccinex, Inc.

Experienced investors utilize this filter to screen out companies with critical liquidity shortages. The metric is calculated as the ratio of available cash reserves to the number of shares outstanding, determining the business's financial cushion. For Vaccinex, Inc. (VCNX), this resource is critical when funding costly developments of antibodies against cancer and degenerative brain pathologies. Analyzing cash per share allows for an assessment of the issuer's ability to sustain R&D without emergency equity offerings. The cash per share trend reflects the balance between survival and capital efficiency.

Perusahaan pesaing

IBRX - Volume dana dhuwit saben saham|Dhuwit awis saben siji saham IMCR (Immunocore PLC)|Dhuwit awis diétung saben siji saham JANX|Dhuwit awis saben saham RCUS (Arcus Biosciences)|Gunggung dhuwit awis saben saham ZYME|tangotx.com - Dhuwit awis saben saham|Cekelan dhuwit saben saham Iovance Corp|Immatics N.V. (IMTX) - Dana dhuwit saben saham|Xencor, Inc. - Gunggung dhuwit awis saben saham|CMPX (compasstherapeutics.com) - Dhuwit awis saben saham|Dhuwit awis saben saham Replimune Group Inc|Dana dhuwit saben saham Lyell Immunopharma, Inc. (LYEL)|IPHA: Dhuwit awis saben lembar saham|Pyxis Oncology - Dhuwit awis saben siji saham|Compugen Limited (CGEN) - Cekelan dhuwit saben saham|IO Biotech Inc - Dhuwit awis saben saham|Dana dhuwit diétung saben saham Sutro Bio STRO|INKT: Dhuwit awis saben saham|Cekelan dhuwit saben saham Werewolf (HOWL)|Dana dhuwit saben saham immixbio.com|Dana dhuwit saben siji saham ALXO (ALX Oncology)|Dhuwit awis saben saham CUE|PDSB (PDS Biotechnology Corporation) - Gunggung dhuwit awis saben saham|Dhuwit awis saben saham SONN (Sonnet BioTherapeutics Holdings)|Gunggung dhuwit awis saben saham MAIA|Liminatus - Dhuwit awis saben saham|lavatherapeutics.com - Dhuwit awis diétung saben siji saham|NextCure (NXTC) - Dana dhuwit saben saham|Leap Therapeutics Inc - Gunggung dhuwit awis saben saham|Dhuwit awis saben siji saham INTS|Dana dhuwit saben saham SNSE|Dhuwit awis saben saham TOVX|GRTS - Cekelan dhuwit saben saham|Dana dhuwit saben saham kinetabio.com KA|Gunggung dhuwit awis saben saham NEXI|turnstonebio.com - Dhuwit awis saben saham|Cekelan dhuwit saben saham Harpoon Therapeutics Corp